Jafeen Ilmudeen
Family Medicine · Brooklyn, NYNPI 1730534983
Payments from drug & device makers
Across 25 payments — averaging $28.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$164
- Novo Nordisk$138
- GSK$128
- Madrigal Pharmaceuticals$85
- Dynavax Technologies Corporation$55
- Pfizer$53
- plus $93 from 3 others
What the payments were for
- Food & beverage$715100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $164 |
| Novo Nordisk | 1 | $138 |
| GSK | 5 | $128 |
| Madrigal Pharmaceuticals | 3 | $85 |
| Dynavax Technologies Corporation | 2 | $55 |
| Pfizer | 2 | $53 |
| Exact Sciences | 2 | $45 |
| Bayer | 1 | $31 |
| Alk-abello, Inc | 1 | $17 |
How this compares
$715 in reported general payments places this provider in the 60th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,281 |
| Atorvastatin Calcium | 120 | $1,227 |
| Rosuvastatin Calcium | 37 | $673 |
| Amlodipine Besylate | 111 | $506 |
| Metoprolol Succinate | 27 | $482 |
| Simvastatin | 38 | $430 |
| Levothyroxine Sodium | 26 | $367 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $349 |
| Nifedipine ErNifedipine | 11 | $249 |
| Losartan Potassium | 27 | $221 |
| Labetalol Hcl | 12 | $206 |
| Fluticasone Propionate | 22 | $202 |
| Triamcinolone Acetonide | 14 | $178 |
| Escitalopram Oxalate | 21 | $174 |
| Metformin Hcl ErMetformin Hcl | 18 | $132 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brooklyn
- Michael YuryevBrooklyn$589K
- Matthew SpitzerBrooklyn$469K
- Walford LindoBrooklyn$104K
- Fu Fu HeBrooklyn$101K
- Jonathan ChangBrooklyn$66K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.